494 related articles for article (PubMed ID: 23280993)
41. Long-term functional and neurological outcome after simultaneous treatment with tissue-plasminogen activator and hyperbaric oxygen in early phase of embolic stroke in rats.
Michalski D; Küppers-Tiedt L; Weise C; Laignel F; Härtig W; Raviolo M; Schneider D; Hobohm C
Brain Res; 2009 Dec; 1303():161-8. PubMed ID: 19766603
[TBL] [Abstract][Full Text] [Related]
42. Role of von Willebrand factor and ADAMTS-13 in early brain injury after experimental subarachnoid hemorrhage.
Wan H; Wang Y; Ai J; Brathwaite S; Ni H; Macdonald RL; Hol EM; Meijers JCM; Vergouwen MDI
J Thromb Haemost; 2018 Jul; 16(7):1413-1422. PubMed ID: 29729651
[TBL] [Abstract][Full Text] [Related]
43. Protective effects of angiopoietin-like 4 on the blood-brain barrier in acute ischemic stroke treated with thrombolysis in mice.
Zhang B; Xu X; Chu X; Yu X; Zhao Y
Neurosci Lett; 2017 Apr; 645():113-120. PubMed ID: 28267563
[TBL] [Abstract][Full Text] [Related]
44. Rosiglitazone ameliorates tissue plasminogen activator-induced brain hemorrhage after stroke.
Li Y; Zhu ZY; Lu BW; Huang TT; Zhang YM; Zhou NY; Xuan W; Chen ZA; Wen DX; Yu WF; Li PY
CNS Neurosci Ther; 2019 Dec; 25(12):1343-1352. PubMed ID: 31756041
[TBL] [Abstract][Full Text] [Related]
45. Randomized, Multicenter Trial of ARTSS-2 (Argatroban With Recombinant Tissue Plasminogen Activator for Acute Stroke).
Barreto AD; Ford GA; Shen L; Pedroza C; Tyson J; Cai C; Rahbar MH; Grotta JC;
Stroke; 2017 Jun; 48(6):1608-1616. PubMed ID: 28507269
[TBL] [Abstract][Full Text] [Related]
46. Vepoloxamer Enhances Fibrinolysis of tPA (Tissue-Type Plasminogen Activator) on Acute Ischemic Stroke.
Wang C; Huang R; Li C; Lu M; Emanuele M; Zhang ZG; Chopp M; Zhang L
Stroke; 2019 Dec; 50(12):3600-3608. PubMed ID: 31587657
[TBL] [Abstract][Full Text] [Related]
47. Whole body hypothermia extends tissue plasminogen activator treatment window in the rat model of embolic stroke.
Hassanipour M; Zarisfi M; Ehsani V; Allahtavakoli M
Life Sci; 2020 Sep; 256():117450. PubMed ID: 32087233
[TBL] [Abstract][Full Text] [Related]
48. NURR1 involvement in recombinant tissue-type plasminogen activator treatment complications after ischemic stroke.
Merino-Zamorano C; Hernández-Guillamon M; Jullienne A; Le Béhot A; Bardou I; Parés M; Fernández-Cadenas I; Giralt D; Carrera C; Ribó M; Vivien D; Ali C; Rosell A; Montaner J
Stroke; 2015 Feb; 46(2):477-84. PubMed ID: 25503547
[TBL] [Abstract][Full Text] [Related]
49. Quantitative MRI reveals the elderly ischemic brain is susceptible to increased early blood-brain barrier permeability following tissue plasminogen activator related to claudin 5 and occludin disassembly.
Kaur J; Tuor UI; Zhao Z; Barber PA
J Cereb Blood Flow Metab; 2011 Sep; 31(9):1874-85. PubMed ID: 21610723
[TBL] [Abstract][Full Text] [Related]
50. Combined tissue plasminogen activator and an NK1 tachykinin receptor antagonist: an effective treatment for reperfusion injury following acute ischemic stroke in rats.
Turner RJ; Vink R
Neuroscience; 2012 Sep; 220():1-10. PubMed ID: 22750240
[TBL] [Abstract][Full Text] [Related]
51. The novel proteasome inhibitor BSc2118 protects against cerebral ischaemia through HIF1A accumulation and enhanced angioneurogenesis.
Doeppner TR; Mlynarczuk-Bialy I; Kuckelkorn U; Kaltwasser B; Herz J; Hasan MR; Hermann DM; Bähr M
Brain; 2012 Nov; 135(Pt 11):3282-97. PubMed ID: 23169919
[TBL] [Abstract][Full Text] [Related]
52. Effects of tissue plasminogen activator on cerebral microvessels of rats during focal cerebral ischemia and reperfusion.
Yang DY; Pan HC; Chen CJ; Cheng FC; Wang YC
Neurol Res; 2007 Apr; 29(3):274-82. PubMed ID: 17509227
[TBL] [Abstract][Full Text] [Related]
53. Remote ischemic conditioning attenuates blood-brain barrier disruption after recombinant tissue plasminogen activator treatment via reducing PDGF-CC.
He Q; Ma Y; Fang C; Deng Z; Wang F; Qu Y; Yin M; Zhao R; Zhang D; Guo F; Yang Y; Chang J; Guo ZN
Pharmacol Res; 2023 Jan; 187():106641. PubMed ID: 36587812
[TBL] [Abstract][Full Text] [Related]
54. Infarct reduction in rats following intraventricular administration of either tissue plasminogen activator (tPA) or its non-protease mutant S478A-tPA.
Yi JS; Kim YH; Koh JY
Exp Neurol; 2004 Oct; 189(2):354-60. PubMed ID: 15380485
[TBL] [Abstract][Full Text] [Related]
55. The role of ADAMTS13 in acute myocardial infarction: cause or consequence?
Eerenberg ES; Teunissen PF; van den Born BJ; Meijers JC; Hollander MR; Jansen M; Tijssen R; Beliën JA; van de Ven PM; Aly MF; Kamp O; Niessen HW; Kamphuisen PW; Levi M; van Royen N
Cardiovasc Res; 2016 Aug; 111(3):194-203. PubMed ID: 27174213
[TBL] [Abstract][Full Text] [Related]
56. PI3Kγ (Phosphoinositide 3-Kinase-γ) Inhibition Attenuates Tissue-Type Plasminogen Activator-Induced Brain Hemorrhage and Improves Microvascular Patency After Embolic Stroke.
Jin R; Xiao AY; Li J; Wang M; Li G
Hypertension; 2019 Jan; 73(1):206-216. PubMed ID: 30571560
[TBL] [Abstract][Full Text] [Related]
57. Cathepsin K Knockout Exacerbates Haemorrhagic Transformation Induced by Recombinant Tissue Plasminogen Activator After Focal Cerebral Ischaemia in Mice.
Zhao R; He XW; Shi YH; Liu YS; Liu FD; Hu Y; Zhuang MT; Feng XY; Zhao L; Zhao BQ; Liu HQ; Shi GP; Liu JR
Cell Mol Neurobiol; 2019 Aug; 39(6):823-831. PubMed ID: 31065924
[TBL] [Abstract][Full Text] [Related]
58. Tissue Plasminogen Activator Promotes TXNIP-NLRP3 Inflammasome Activation after Hyperglycemic Stroke in Mice.
Ismael S; Nasoohi S; Yoo A; Ahmed HA; Ishrat T
Mol Neurobiol; 2020 Jun; 57(6):2495-2508. PubMed ID: 32172516
[TBL] [Abstract][Full Text] [Related]
59. Effects of minocycline plus tissue plasminogen activator combination therapy after focal embolic stroke in type 1 diabetic rats.
Fan X; Lo EH; Wang X
Stroke; 2013 Mar; 44(3):745-52. PubMed ID: 23422086
[TBL] [Abstract][Full Text] [Related]
60. A broad-spectrum matrix metalloproteinase inhibitor prevents hemorrhagic complications induced by tissue plasminogen activator in mice.
Mishiro K; Ishiguro M; Suzuki Y; Tsuruma K; Shimazawa M; Hara H
Neuroscience; 2012 Mar; 205():39-48. PubMed ID: 22244977
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
